Literature DB >> 19936877

The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia.

Shoichi Kobayashi1, Masato Obata1, Maki Hagihara2, Kenji Motohashi2, Satomi Ito2, Rika Ohshima2, Rika Sakai2, Atsuo Maruta2, Heiwa Kanamori3.   

Abstract

We observed the mature granulocytes/monocytes derived from leukemic cells in patients with acute myeloid leukemia who present mixed lineage leukemia gene (MLL). Morphologic observation and fluorescence in situ hybridization analysis (FISH) for chromosome 11q23 abnormality were studied, and a multiplex reverse transcriptase-polymerase chain reaction (RT-PCR) analysis was done to identify the fusion partners with MLL. The bone marrow cells with FISH signals of MLL showed the cell differentiation of the myeloid and/or monocytic lineages in 4 of 6 AML patients. MLL partner genes were AF6, AF9, ELL, and ENL, respectively. There was no correlation between the fusion partner and the appearance of mature cells derived from MLL clones. RT-PCR showed the fusion between MLL exon 9 or 10 and the partner genes in mature granulocytes/monocytes. These findings suggest that subgroup of leukemia cells with MLL rearrangement has the differentiation potential of leukemic cells and mature granulocytes/monocytes derived from MLL clones may be biologically different from normal mature cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19936877     DOI: 10.1007/s12185-009-0441-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  15 in total

Review 1.  Topoisomerase II inhibitor-related acute myeloid leukaemia.

Authors:  C H Pui; M V Relling
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

2.  Clonal expansion of a new MLL rearrangement in the absence of leukemia.

Authors:  Oliver Teuffel; David R Betts; Marco Thali; Dominique Eberle; Claus Meyer; Björn Schneider; Rolf Marschalek; Luba Trakhtenbrot; Ninette Amariglio; Felix K Niggli; Beat W Schäfer
Journal:  Blood       Date:  2005-05-15       Impact factor: 22.113

3.  Clonal expansion of non-leukemic cells expressing two novel MLL-ELL variants differing in transforming activity.

Authors:  M Takeuchi; C Nakaseko; S Miyagi; Y Takeda; S Ozawa; C Ohwada; R Cho; M Nishimura; Y Saito; A Iwama
Journal:  Leukemia       Date:  2007-09-20       Impact factor: 11.528

4.  The mechanism of hematopoietic progenitor cell immortalization by MLL-ENL.

Authors:  Sarah J Horton; Owen Williams
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

5.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Authors:  J M Bennett; D Catovsky; M T Daniel; G Flandrin; D A Galton; H R Gralnick; C Sultan
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

6.  Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia.

Authors:  N Pallisgaard; P Hokland; D C Riishøj; B Pedersen; P Jørgensen
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

7.  Mechanisms of transcriptional regulation by MLL and its disruption in acute leukemia.

Authors:  Yali Dou; Jay L Hess
Journal:  Int J Hematol       Date:  2007-12-04       Impact factor: 2.490

8.  MLL gene fusions in human leukaemias: in vivo modelling to recapitulate these primary tumourigenic events.

Authors:  S Rodriguez-Perales; F Cano; M N Lobato; T H Rabbitts
Journal:  Int J Hematol       Date:  2007-11-17       Impact factor: 2.490

9.  AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases.

Authors:  Claudia Schoch; Susanne Schnittger; Mirjam Klaus; Wolfgang Kern; Wolfgang Hiddemann; Torsten Haferlach
Journal:  Blood       Date:  2003-06-12       Impact factor: 22.113

10.  Continuous MLL-ENL expression is necessary to establish a "Hox Code" and maintain immortalization of hematopoietic progenitor cells.

Authors:  Sarah J Horton; David G Grier; Glenda J McGonigle; Alexander Thompson; Michelle Morrow; Inusha De Silva; Dale A Moulding; Dimitris Kioussis; Terence R J Lappin; Hugh J M Brady; Owen Williams
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.